Ensuring Timely Access to Generics Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 3
- Latest action
- Oct 16, 2025
What it does
The Ensuring Timely Access to Generics Act of 2025 would amend the Federal Food, Drug, and Cosmetic Act to strengthen requirements for citizen petitions related to drug applications, aiming to prevent frivolous or delaying petitions that block generic drug approvals. It would require individuals to submit a citizen petition to the FDA before filing certain civil actions challenging drug applications, mandating that such petitions be filed within 180 days of learning the relevant information and include all supporting arguments. The bill also establishes specific factors the Secretary of Health and Human Services may consider to determine if a petition was submitted primarily to delay…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.